FOXC2 expression and epithelial–mesenchymal phenotypes are associated with castration resistance, metastasis and survival in prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

FOXC2 expression and epithelial–mesenchymal phenotypes are associated with castration resistance, metastasis and survival in prostate cancer

Published:2019-10 Issue:4 Volume:5 Page:272-286
ISSN:2056-4538
Container-title:The Journal of Pathology: Clinical Research
language:en
Short-container-title:J Pathol Clin Res

Author:

Børretzen Astrid¹²,Gravdal Karsten¹²,Haukaas Svein A³⁴,Beisland Christian³⁴,Akslen Lars A¹²,Halvorsen Ole J¹²

Affiliation:

1. Centre for Cancer Biomarkers CCBIO, and Gade Laboratory for Pathology, Department of Clinical MedicineUniversity of Bergen Bergen Norway

2. Department of PathologyHaukeland University Hospital Bergen Norway

3. Department of Clinical MedicineUniversity of Bergen Bergen Norway

4. Department of UrologyHaukeland University Hospital Bergen Norway

Funder

Universitetet i Bergen

Kreftforeningen

Helse Vest

Norges Forskningsråd

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cjp2.142

Reference51 articles.

1. Emerging roles and mechanisms of FOXC2 in cancer

3. Epithelial-Mesenchymal Transitions in Development and Disease

4. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

5. Molecular mechanisms of epithelial–mesenchymal transition

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Calcium-Mediated Cell Adhesion Enhancement-Based Antimetastasis and Synergistic Antitumor Therapy by Conjugated Polymer–Calcium Composite Nanoparticles;ACS Nano;2024-08-28

2. Comprehensive transcriptomic analysis of prostate cancer lung metastases;PLOS ONE;2024-08-15

3. Molecular landscape for risk prediction and personalized therapeutics of castration-resistant prostate cancer: at a glance;Frontiers in Endocrinology;2024-06-03

4. Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response;Cancer and Metastasis Reviews;2024-01-16

5. FOXS1 promotes prostate cancer progression through the Hedgehog/Gli1 pathway;Biochemical Pharmacology;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3